CatalystWireBeta

Change of advisor

In brief · summary, not quotable

No summary for this filing – the full text is below.

Full announcement

Select text to share a quote on X · sign in to keep highlights & notes in your SBTX notes

22 May 2025 - SkinBioTherapeutics plc (AIM: SBTX, the Group), a life science company focused on skin health, announces that it has appointed Singer Capital Markets as its Nominated Adviser and Sole Broker with immediate effect.

Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note